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Abstract
Social capital, the sum of an individual’s resource-containing social network connections, has 
been proposed as a facilitator of successful HIV care engagement. We explored relationships 
between social capital, psychological covariates (depression, stigma and internalized 
homonegativity), and viral suppression in a sample of young Black gay, bisexual and other men 
who have sex with men (YB-GBMSM). We recruited 81 HIV-positive YB-GBMSM 18–24 years 
of age from a clinic setting. Participants completed a cross-sectional survey, and HIV-1 viral load 
(VL) measurements were extracted from the medical record. Sixty-five percent (65%) were virally 
suppressed (HIV-1 VL ≤ 40 copies/ml). Forty-seven percent (47%) had a positive depression 
screen. Depressive symptoms affected viral suppression differently in YB-GBMSM with lower vs. 
higher social capital (p = 0.046, test for statistical interaction between depression and social 
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capital). The odds of viral suppression among YB-GBMSM with lower social capital was 93% 
lower among those with depressive symptoms (OR= 0.07, p= 0.002); however, there was no 
association between depressive symptoms and viral suppression among those with higher social 
capital. Our results suggest that social capital may buffer the strong negative effects of depressive 
symptoms on clinical outcomes in YB-GBMSM living with HIV. In addition to treating 
depression, there is a role for interventions to augment social capital among YB-GBMSM living 
with HIV as a strategy for enhancing care engagement.
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INTRODUCTION
Social capital, defined here as “the net worth of an individual’s resource-containing 
reciprocal, and trustworthy social network connections” (1, 2), has been proposed as a 
potentially powerful facilitator of care engagement for people living with HIV (3, 4). 
Despite high levels of interest in social capital internationally, there is relatively little 
research focused on social capital among key HIV-affected populations in the United States 
(US), such as young Black gay, bisexual, and other men who have sex with men (YB-
GBMSM). YB-GBMSM have the highest HIV incidence rates of any demographic group in 
the US (5), and they are also at risk for suboptimal engagement outcomes across the HIV 
care continuum, including lower rates of linkage to care, retention in care, and viral 
suppression relative to older, White, or female individuals living with HIV (6, 7). Given the 
critical importance of engagement in HIV care for both individual and public health, 
identifying facilitators of care engagement for YB-GBMSM living with HIV could be 
critically important for policy, programming and intervention development.
Although social capital per se remains underexplored among YB-GBMSM living with HIV 
in the US, there is ample evidence of the significance of social relationships in their lives. 
Previous research has identified biological family, friends, and other natural mentors as 
important social connections and sources of support for YB-GBMSM (8, 9). At the dyadic 
level, social relationships have been successfully used to enhance medication adherence and 
retention in care among YB-GBMSM through identification of a support person within their 
existing networks (10, 11). Additionally, researchers have described unique endogenous 
social structures within YB-GBMSM communities such as the house/ball scene (in which 
groups called “houses” composed primarily of YB-GBMSM compete against one another in 
underground dance events known as “balls”) and surrogate “gay families” that provide 
important social resources for their members (12, 13). Taken together, this body of research 
provides indirect evidence to support the potential role of social capital in enhancing HIV 
care engagement in this population.
Although this topic is understudied in the US, research highlighting the role of social capital 
in HIV care has previously been conducted in diverse international settings. A multi-country 
ethnographic study in sub-Saharan Africa, for example, found social capital to be both a 
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direct and indirect facilitator of care engagement among people living with HIV (14, 15). 
The direct effects of social capital were illustrated by individuals describing use of social 
connections to address concrete barriers to care such as transportation and financial needs. 
At other times, social capital also acted indirectly as a buffer; for example, when supportive 
social connections helped people to cope with the adverse mental health consequences of 
stigmatizing community attitudes. Studies of women and children living with HIV in 
Ethiopia and Kenya have similarly highlighted the positive role of social capital in coping 
and resilience in these key populations (16, 17). Importantly, social capital is not only an 
important influence on care engagement, it is also a potentially modifiable resource that can 
serve as an intervention target (3, 18). Several types of interventions have been developed to 
enhance social capital among populations infected with, or at risk for HIV; these include 
peer-based interventions, community empowerment interventions, group-based microfinance 
interventions and support group interventions (3).
To date, social capital has not been specifically linked to HIV care outcomes among YB-
GBMSM in the US. Inquiry into the functioning of social capital among YB-GBMSM may 
help to identify novel targets for innovative interventions aiming to improve HIV care 
engagement among YB-GBMSM. We therefore sought to explore direct and indirect effects 
of social capital in a clinic-recruited sample of YB-GBMSM living with HIV.
Theoretical Background
As noted above, we define social capital from the individual’s perspective as “the net worth 
of an individual’s resource-containing reciprocal, and trustworthy social network 
connections” (1, 2). Social capital is a multidimensional construct that includes structural, 
cognitive and functional features of social networks (19). Features such as the size and 
diversity of a person’s network, as well as the socioeconomic and other resources owned by 
contacts in that network, all have a bearing on the social capital that can be derived therein 
(20, 21). Social capital can further be divided into two main subtypes: bonding capital and 
bridging capital (22). Bonding capital refers to resources accessed within social groups 
whose members are relatively similar in terms of sociodemographic factors (e.g., emotional 
support from close friends of similar cultural and economic backgrounds), while bridging 
capital refers to resources derived from cross-identity connections (e.g., information about a 
job opportunity from a co-worker who is not from the same demographic group) (22). Both 
bonding and bridging capital have been theorized to have positive impacts on health 
outcomes.
A few conceptual distinctions are worth noting. Our focus on personally owned social 
capital (inherent in an individual’s network connections) differs from that of scholars who 
measure social capital and its effects at the community level (e.g., focusing on the levels of 
social cohesion and civic participation within communities) (19, 23, 24). Although both 
personal and community-level social capital have important implications for HIV, we were 
interested in individual-level clinical outcomes for the purpose of this analysis and therefore 
chose to focus on the role of personal social capital in HIV care engagement. Finally, it is 
worth noting the distinction between social capital and social support, as these are closely 
related but separate constructs. Social capital is a description of the resources (including 
Hussen et al. Page 3
AIDS Behav. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
emotional social support, but also other factors such as information channels or social 
credentials) available in an individual’s social network (25). On the other hand, social 
support measures tend to focus more on an individual’s satisfaction with the support they 
receive, as opposed to assessing the potential for support in the network as a whole (26–28).
In our review of the literature on social capital and HIV care outcomes, several factors 
emerged as potentially important covariates that should be included in our analysis: namely, 
depression and stigma. Depressive symptoms have repeatedly been demonstrated to impede 
effective engagement in care among people living with HIV. Prior research has delineated 
negative relationships between depression and a range of outcomes along the HIV care 
continuum, including medication adherence/acceptance (29–31), missed clinic visits (32), 
and viral suppression (31). Depression is also a common mental health problem, with a 
disproportionately high prevalence among youth living with HIV (29). Of note, prior 
research in other vulnerable populations, such as homeless individuals and victims of natural 
disasters, suggests that social capital can have a significant and beneficial impact on levels of 
depressive symptoms (33–35).
Stigma is another factor that is important for HIV care engagement and may be related to 
depression and social capital among YB-GBMSM and other people living with HIV. Ware et 
al.’s work in sub-Saharan Africa specifically cited stigma as a major barrier to care that 
appeared to be buffered by social capital (14). It is important to note that GBMSM are often 
subject to multiple stigmas, including HIV-specific stigma as well as stigma related to same-
sex identity. Aspects of both HIV stigma and internalized homonegativity have been 
negatively associated with medical appointment adherence among YB-GBMSM in our 
previous research (36, 37).
The current analysis is an exploratory study that was designed to examine associations 
between social capital and HIV viral suppression (the ultimate measure of engagement along 
the HIV care continuum) among YB-GBMSM. We hypothesized that social capital would 
be positively associated with HIV viral load suppression, and therefore designed the study to 
address the following objectives: (1) To determine whether social capital (total social capital, 
bonding social capital and bridging social capital) had a positive direct association with HIV 
viral load suppression; (2) To determine whether any relationship between social capital and 
HIV viral load suppression was confounded by depressive symptoms, HIV stigma, and/or 
internalized homonegativity. (3) To determine whether social capital might indirectly impact 
(act as an effect modifier) between psychosocial covariates (depressive symptoms, stigma, 
internalized homonegativity) and HIV viral load suppression.
METHODS
We recruited 81 YB-GBMSM living with HIV from a pediatric/adolescent clinic in a large 
Southeastern city in the United States, between November 2015 and July 2016. Potential 
participants were approached during their visits to medical providers or other support staff in 
the clinic. Patients who self-identified as Black and male, reported a history of ever having 
sex with a male partner, and had been in care at the clinic for at least one year, were invited 
to participate. This was largely a convenience sample; however, in an effort to recruit a 
Hussen et al. Page 4
AIDS Behav. Author manuscript; available in PMC 2019 September 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
sample that included incompletely engaged individuals, we stratified our recruitment so that 
half of the participants had missed more than 25% of their scheduled visits within the 
previous year, while the other half had not. Participants completed a one-time Audio 
Computer Assisted Self Interview (ACASI) that included measures of social capital, 
depressive symptoms, and other psychosocial constructs. A trained graduate research 
assistant subsequently abstracted clinical data from the patient’s electronic medical record 
(EMR), including scheduled and missed appointments as well as the most recent viral load 
measurement.
Measures
Social Capital—We modified Chen’s Personal Social Capital Scale (2) in order to 
measure social capital in our participants. This scale contains 10 items with 49 sub-items; 
each sub-item is scored on a Likert-type scale ranging from 1 to 5 and each item’s score is 
the mean of the sub-item scores. Total scale scores therefore range from 10 (lowest social 
capital) to 50 (highest social capital). The Personal Social Capital Scale is theoretically 
based and contains subscales that measure bonding capital and bridging capital. Of note, 
however, this measure was originally developed for use among adults in China and therefore 
contained items not likely to apply in our context.
In order to modify the scale for use among YB-GBMSM, our study team (consisting of 
researchers with experience working directly with YB-GBMSM in our local community) 
first examined each scale item and changed wording that was unlikely to be relevant for our 
participants or that might be difficult to understand (e.g., references to “country fellows”). 
We also added items that seemed likely to be important for our participants based on our 
prior work with YB-GBMSM (e.g., questions about lesbian, gay, bisexual, transgender and 
queer [LGBTQ] organizations and college fraternities). Next, we conducted individual 
cognitive interviews with a convenience sample of five YB-GBMSM to solicit input on the 
readability, clarity and content of the scale. We added items and clarified wording based on 
their feedback. Finally, we piloted the modified scale in an online sample of n=204 
geographically diverse YB-GBMSM aged 18–29 recruited via a popular social networking 
website that caters specifically to Black GBMSM, and found the scale to have excellent 
reliability in that sample (α=0.88); the same was true in the current sample (α=0.86).
Depression—We utilized the Centers for Epidemiologic Studies-Depression Revised 
version (CESD-R) to measure depressive symptoms (38). The CESD-R is a 20-item scale 
that requires participants to characterize their frequency of depressive symptoms using a 5-
point Likert scale ranging from 0 (not at all or less than 1 day last week) to 4 (nearly every 
day for two weeks). A score of ≥16 is consistent with clinically significant depressive 
symptoms. (39) The CESD-R has demonstrated validity and reliability in numerous other 
studies of people living with HIV (40). Reliability was excellent in our sample as well (α 
=0.91).
HIV Stigma—This construct was measured using the Revised HIV Stigma scale for youth, 
a 10-item scale that asks participants to rate their agreement with various statements about 
attitudes towards people with HIV, disclosure concerns, and negative self-image (41). The 
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scale utilizes a 4-point Likert scale ranging from 1 (strongly agree) to 4 (strongly disagree) 
and was reliable in our sample (α =0.84).
Internalized Homonegativity—We utilized Mayfield’s Internalized Homonegativity 
Inventory (IHNI) to measure this construct (42). This measure asks participants to rate their 
agreement with a series of statements about their feelings regarding their own sexual 
orientation, using a 6-point Likert scale ranging from 1 (strongly disagree) to 6 (strongly 
agree). The IHNI had excellent reliability in our sample (α=0.92).
Viral Suppression—Viral suppression was defined here as HIV-1 RNA (viral load) below 
the limit of detection for the assay used in the clinical encounter. The most commonly used 
assays have lower limits of either 20 or 40 copies/mL, depending on the patient’s insurance 
provider (or lack thereof), which in turn determines the laboratory that ultimately performs 
the test. We utilized the participant’s most recent viral load measurement, which was in most 
cases collected on the date of the survey, and which was always within 90 days of the survey 
date.
Analysis
The potential association of each of the factors in Table 2 with the outcome (viral 
suppression) was evaluated using logistic regression modeling. Odds ratios (ORs) were 
calculated to measure the degree of association between risk factors and viral suppression. 
Continuous predictors were included in the logistic regression models assuming a linear 
relationship between these predictors and viral suppression. Additionally, continuous 
predictors were dichotomized at the median, assuming the relationship between the predictor 
and viral suppression was flat within the intervals.
Due to the limited number of patients without viral suppression and concern for model 
overfitting, covariates included in multivariable logistic regression analyses were limited to 
main effects. Covariate selection was driven by available knowledge, theoretical 
expectations, and biological plausibility of potential confounders, taking into consideration 
the hypothesis of interest. The adjusted OR and its 95% confidence interval were calculated 
for each risk factor in the presence of others in the final models.
Subgroup analyses were used to evaluate potential moderating effects of total, bonding and 
bridging social capital on the relationship between depressive symptoms and viral 
suppression. The effect of total social capital (and separately, bonding social capital and 
bridging social capital) was investigated by including the statistical interaction between 
depressive symptoms (CESD-R: <16 or ≥16) and social capital in a logistic regression 
model.
RESULTS
Sample Characteristics
Our sample ranged in age from 18–24 years (mean=22, SD= 1.5). A large majority (84%) 
described their sexual orientation as gay, with few participants self-identifying as bisexual, 
straight/heterosexual or questioning/unsure. Most had completed at least a high school 
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diploma or General Education Development (GED – high school equivalency) certification, 
and many had started college or technical school as well. Two-thirds reported current 
employment. In terms of their engagement in care, half of the sample had missed over 25% 
of their appointments, and 71.6% had missed at least one appointment. In spite of this, 56/81 
(69.1%) self-reported very good or excellent adherence, and 53/81 (65.4%) were virally 
suppressed at the time of the survey (Table 1).
The prevalence of depressive symptoms was high in our sample. Nearly half (47%) of our 
participants scored above the CESD-R cutoff for depressive symptoms. The mean social 
capital score was 25 (SD=6.4), which is comparable to results among Chinese respondents 
in Chen’s original scale validation study (2).
Bivariable analyses
Participants with lower total social capital (below the median of 25) were less likely to be 
virally suppressed compared to participants with higher total social capital (59% vs. 73%, 
OR 0.54, 95% CI 0.28–1.04; p=0.06, Table 2); this finding approached but did not quite 
reach statistical significance. We also analyzed the subscales of social capital to test their 
separate relationships with viral suppression and found that low bonding social capital 
(below the median of 12) retained this relationship with viral suppression (OR 0.54, 95% CI 
0.28–1.04; p=0.06), while bridging social capital did not appear to be related (OR 0.96, 95% 
CI 0.39–2.41; p=0.93). Participants with depressive symptoms (CESD-R ≥ 16) were less 
likely to be virally suppressed (18/38, 47%) compared to participants who did not have 
depressive symptoms (35/43, 81%; OR 0.21, 95% CI 0.10–0.42; p<0.01). Several other 
baseline demographic characteristics summarized in Table 2 (i.e. older age, housing stability 
within last 6 months) also displayed significant associations with viral suppression.
Multivariable analyses
From multivariable logistic regression, only depressive symptoms remained associated with 
viral suppression (Table 3). Total social capital, HIV stigma, internalized homonegativity, 
bonding social capital (data not shown) and bridging social capital (data not shown) were 
not independent predictors of viral suppression. The adjusted odds of viral suppression was 
significantly lower in participants with depressive symptoms compared to participants who 
were not depressed (adjusted OR 0.26, 95% CI 0.09–0.78; p = 0.02, Table 3).
Subgroup analyses
We found evidence of effect modification by total social capital on the association between 
depressive symptoms and viral suppression. When comparing YB-GBMSM with lower total 
social capital (below the median score of 25; N=41) to YB-GBMSM with higher total social 
capital (above 25; N=40), the interaction was significant (Table 4, test for statistical 
interaction between depressive symptoms and total social capital, p=0.046). There was no 
association between depressive symptoms and viral suppression among those with higher 
total social capital (OR 0.63, 95% CI 0.15–2.59; p=0.52). However, the odds of viral 
suppression among YB-GBMSM with lower total social capital was 93% lower in depressed 
participants compared to participants without depressive symptoms (OR 0.07, 95% CI 0.01–
0.37; p=0.002).
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We also examined potential moderating effects of the social capital subscales (bonding and 
bridging capital) on the relationship between depressive symptoms and viral suppression. In 
these cases, the interaction was not significant; neither bonding nor bridging capital alone 
moderated the relationship between depressive symptoms and viral suppression (test for 
statistical interaction between depressive symptoms and bonding social capital, p=0.31; test 
for statistical interaction between depressive symptoms and bonding social capital, p=0.11; 
data not shown).
DISCUSSION
The prevalence of depressive symptoms in our sample was high, even compared with other 
studies of US youth living with HIV (29, 43, 44). The strong association between depressive 
symptoms and lack of viral suppression, which has been well documented in other studies of 
youth living with HIV (43, 45), was further supported here in our specific study sample of 
YB-GBMSM. There also appeared to be a trend towards a direct association between level 
of social capital (particularly the bonding capital component) and the likelihood of viral 
suppression. Importantly, for patients with depressive symptoms, social capital was a 
protective factor – the detrimental effect of depressive symptoms on viral suppression was 
worse for those with low social capital. These results were consistent with our theoretical 
expectations, and with several other studies that examined related study questions in similar 
populations (46, 47).
The stronger association of bonding social capital (relative to bridging social capital) with 
viral suppression was a notable finding. Previous research on the influence of bonding and 
bridging capital on health has yielded conflicting results. The importance of bonding social 
capital has been demonstrated for mental health in particular (19, 48). However, others have 
also highlighted stress and strain that can result from the close social networks that yield 
bonding social capital, as such networks may produce conflicts, envy, or more onerous 
obligations for their members (20, 49). On the other hand, certain scholars have highlighted 
the relative importance of bridging capital, or “weak ties” that link individuals to resources 
they would not normally be able to access. For example, a study focused on health 
information seeking among Black adults highlighted the importance of bridging ties to 
healthcare professionals as integral to the process of seeking healthcare information (50). 
For our sample of YB-GBMSM, however, the associations with bonding social capital, 
appeared to be more positive than negative (and stronger than associations with bridging 
capital) for the health outcome in question. Our findings are consistent with some, but not 
all, literature in the field, highlighting the population-specific and disease-specific nature of 
these constructs and conceptual relationships.
The function of social capital as a buffer against depressive symptoms is consistent with a 
prior US study that found social network factors (including size of emotional, financial and 
medical support networks) to be significantly associated with fewer depressive symptoms in 
a mixed-serostatus sample of Black men who have sex with men (MSM) participating in the 
HIV Prevention Trials Network (HPTN) 061 protocol (46). Although this study did not label 
their predictor variables as social capital per se, the size of networks and different support 
functions described by the authors align well with specific items in our measure (e.g., items 
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assessing network size and items assessing the presence of specific assets such as “medical 
or health knowledge”, “large wealth”, etc.) and with the concept of social capital more 
generally.
In another very pertinent study, Friedman et al. utilized data from the Multicenter AIDS 
Cohort Study (MACS) of MSM living with HIV, and found that functional social support (a 
single item measuring the number of people an individual could “count on”) was an effect 
modifier between concomitant syndemic indicators (including depression) and viral 
suppression (47). Again, the authors did not frame their functional social support item in 
terms of social capital theory; however, this measurement of the size of one’s help network 
correlates directly with items on our social capital measure. We should note, however, that 
there are important differences between this study and ours; the majority of the MACS 
cohort is white and over 40 years of age. Nevertheless, the similar findings in terms of the 
effect modifying relationship support the validity of our results and the theoretical 
relationships they suggest.
Limitations and Strengths
Our study has several limitations. Our sample size was small, limiting our ability to make 
statistical inferences. This is in part because we initially powered our study on retention in 
care, and may therefore have been underpowered to detect smaller effect sizes on viral 
suppression. Additionally, the recruitment of patients directly from the clinic setting skewed 
our sample towards those who were more easily able to maintain some level of care 
engagement. To offset this bias, we did purposively recruit our sample so that half of our 
participants were less compliant youth (who had missed 25% or more of their visits in the 
last year). Still, all participants were at least engaged in care enough to come to a clinic visit, 
and future studies should aim to recruit from the community to reach a wider range of YB-
GBMSM. Finally, we recruited from a single site and cannot gauge how generalizable our 
results may or may not be to other geographic or clinical settings – multisite investigations 
are indicated in the future.
Still, several strengths bear mention. In our assessment of care engagement, we were able to 
utilize biological measurements obtained from the EMR abstraction, as opposed to relying 
on participant self-report. Our analysis was culturally specific: to measure social capital, we 
utilized a scale that we had previously adapted and tested specifically in YB-GBMSM – this 
and all reported measures had excellent reliability in our sample. Finally, this analysis 
focused not only on barriers to care (e.g., depressive symptoms) but also began to 
demonstrate the role of social capital – an important, modifiable resilience factor with the 
potential to improve outcomes for YB-GBMSM living with HIV.
Conclusions
Our results suggest a potential role for interventions that augment social capital among YB-
GBMSM living with HIV, particularly for those with depressive symptoms. Interventions 
have previously been developed to intentionally create social capital in non-U.S. settings; 
these include community empowerment interventions, group-based microfinance, support 
groups, and peer-led interventions (3, 18, 51, 52). To our knowledge, however, no such 
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interventions have been specifically developed for YB-GBMSM living with HIV in the 
United States. Future interventions aiming to improve social capital with this population will 
need to be culturally tailored, as the nature and role of social capital varies considerably in 
different cultural and demographic groups (53). However, we believe that social capital-
based interventions hold significant promise for YB-GBMSM. The appeal of a social 
capital-based intervention is that it naturally lends itself to a strengths-based approach – such 
interventions would not need to create new social networks de novo, but could instead build 
upon the naturally existing social structures and mentoring relationships that YB-GBMSM 
often describe (8, 13). By augmenting resources that YB-GBMSM already possess, a social 
capital-based approach has the potential to be a feasible and sustainable way to enhance care 
engagement in this population.
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Table 1
Baseline Characteristics (n = 81)
Age (years) mean ± SD 22.4 ± 1.6
Sexual Orientation
 Gay or homosexual 68 (84.0%)
 Bisexual 9 (11.1%)
 Heterosexual/Straight 1 (1.2%)
 Questioning/Unsure 3 (3.7%)
Education
 Did not complete HS 10 (12.3%)
 HS/GED/Post HS 71 (87.7%)
Current Employment 54 (66.7%)
Missed appointments
 Missed more than 25% appointments 41 (50.6%)
 At least one appointment missed 51 (71.6%)
Self-reported good or excellent adherence 56 (69.1%)
Virologically suppressed 53 (65.4%)
Unless otherwise noted, continuous variables are reported as mean ± SD and categorical variables are reported as no. (%).
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Table 2
Bivariable logistic regression analysis of variables potentially associated with viral suppression
Prevalence of 
viral 
suppression
Odds ratio [95% 
CI]
p
ALL patients 53/81 (65%)
Age <23 20/36 (56%) 0.46 [0.24,0.88 ] 0.019
≥23 33/45 (73%) reference
Education did not complete HS 5/10 (50%) 0.48 [0.19,1.23] 0.13
HS/GED/Post HS 48/71 (68%) reference
Working Yes 39/54 (72%) 2.41 [1.22,4.77 ] 0.011
No 14/27 (52%) reference
Sexual Orientation bisexual, heterosexual/straight, questioning/unsure 7/13 (54%) 0.56 [0.24,1.31 ] 0.18
homosexual/gay 46/68 (68%) reference
Housing 0.0002
Lives alone 31/41 (76%) reference
Living with family 14/19 (74%) 0.90 [0.37,2.18 ]
Other 8/21 (38%) 0.20 [0.09,0.44 ]
Moved in last 6 months No 28/36 (78%) 2.8 [1.4,5.6 ] 0.0036
Yes 25/45 (56%) reference
Total Social Capital (median =25) <25 24/41 (59%) 0.54 [0.28,1.04 ] 0.06
≥25 29/40 (73%) reference
Bonding Social Capital (median 12) <12 24/41 (59%) 0.54 [0.28,1.04 ] 0.06
≥12 29/40 (73%) reference
Bridging Social Capital (median 
13.5)
<13.5 26/40 (65%) 0.96 [0.39,2.41 ] 0.93
≥13.5 27/41 (66%) reference
HIV Stigma (median 26) <26 28/38 (74%) 2.02 [0.79,5.17 ] 0.14
≥26 25/43 (58%) reference
Internalized Homonegativity (median 
48)
<48 30/39 (77%) 2.75 [1.05,7.2 ] 0.04
≥48 23/42 (55%) reference
Depressive Symptoms (CESD-R) <16 Not Depressed 35/43 (81%) reference
≥ 16 Depressed 18/38 (47%) 0.21 [0.1,0.42 ] <.0001
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Table 4
Logistic regression model with total social capital and depressive symptoms plus the interaction as risk factors 
potentially associated with viral suppression
Subgroup Odds Ratio (95% CI) P Value
Depressed: Total social capital (<25 vs ≥25) 0.27 (0.07, 1.05) 0.06
Not Depressed: Total social capital (<25 vs ≥25) 2.53 (0.45, 14.3) 0.30
Low social capital (depressed/not depressed) 0.07 (0.01, 0.37) 0.002
High social capital (depressed/not depressed) 0.63 (0.15, 2.59) 0.52
P value for interaction between total social capital and depressive symptoms = 0.046
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